Skip to main content
Journal ArticleOPEN ACCESS

Controversy of angiotensin receptor blockers (ARBs) and angiotensin converting enzyme inhibitors (ACEIs) prescription for hypertension patients in coronavirus disease 2019 (COVID-19) pandemic

  • Yuliana Y
Journal of thee Medical Sciences (Berkala Ilmu Kedokteran) (2020) 52(03)
DOI: 10.19106/jmedscisi005203202006
N/ACitations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

… Indonesia … Controversy of Angiotensin Receptor Blockers (ARBs) and Angiotensin Converting Enzyme (ACE) Inhibitor Prescription for Hypertension Patients in COVID-19 Pandemic. Yuliana Lee (1*) (1) Anatomy Department Faculty of Medicine, Udayana University …

Cite

CITATION STYLE

APA

Yuliana, Y. (2020). Controversy of angiotensin receptor blockers (ARBs) and angiotensin converting enzyme inhibitors (ACEIs) prescription for hypertension patients in coronavirus disease 2019 (COVID-19) pandemic. Journal of Thee Medical Sciences (Berkala Ilmu Kedokteran), 52(03). https://doi.org/10.19106/jmedscisi005203202006

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free